CA
NZ
UK
AU
IND
US
iRadimed Corporation (NASDAQ: IRMD) shares were trading at USD 84.08 on October 27, 2026, down 0.66%, with a relative volume at time of 2.05. The MRI compatible device maker began general release production of its MRidium 3870 IV infusion pump system in the second …
Labcorp Holdings Inc. (NYSE: LH) shares were trading at USD 326.96 on October 27, 2026, down 0.89%, with a relative volume at time of 2.10. The diagnostics and drug development laboratory company announced a $0.72 per share dividend on July 9, 2026, discussed second …
NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) shares were trading at USD 20.49 on October 27, 2026, up 4.92%, with a relative volume at time of 2.59. The late-stage biopharmaceutical company announced in July 2026 that the CHMP of the European Medicines Agency adopted a …
The Pennant Group, Inc. (NASDAQ: PNTG) shares were trading at USD 41.49 on October 27, 2026, down 2.55%, with a relative volume at time of 2.11. The healthcare services company added six senior living communities in the six months ended June 30, 2026 and …
Prime Medicine, Inc. (NASDAQ: PRME) shares were trading at USD 4.08 on October 27, 2026, up 13.02%, with a relative volume at time of 2.09. The biotechnology company received clearance of the CTA for PM577a in New Zealand in June 2026, received a final …
Repligen Corporation (NASDAQ: RGEN) shares were trading at USD 173.80 on October 27, 2026, down 3.54%, with a relative volume at time of 2.82. The bioprocessing company closed its acquisition of BioLife Solutions on October 6, opened a training center in Seoul on October …
UroGen Pharma Ltd. (NASDAQ: URGN) shares were trading at USD 33.71 on October 27, 2026, down 0.97%, with a relative volume at time of 2.82. The biotechnology company settled its Jelmyto patent litigation with Teva on June 2, 2026, announced a Notice of Allowance …
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) shares were trading at USD 10.21 on October 27, 2026, up 7.14%, with a relative volume at time of 2.41. The rare disease company repaid its term loans in March 2026, entered a settlement with Commave Therapeutics, announced a …
Aclaris Therapeutics (NASDAQ: ACRS) shares were trading at USD 3.75 on October 27, 2026, down 1.06%, with a relative volume at time of 4.55. The clinical-stage biopharmaceutical company announced primary analysis results from two Phase 1b proof-of-concept trials of its bispecific antibody ATI-052 on …
Avalyn Pharma Inc. (NASDAQ: AVLN) shares were trading at USD 25.40 on October 27, 2026, down 6.41%, with a relative volume at time of 4.81. The clinical-stage biopharmaceutical company completed its initial public offering on May 1, 2026, and filed its Form 10-Q for …
Please wait processing your request...